| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Restricted cash | NaN | 595 | 985 | 979 |
| Property and equipment, held for sale | NaN | 157 | NaN | NaN |
| Cash and cash equivalents | 1,168 | 4,360 | 6,923 | 14,046 |
| Other current assets | 1,875 | 463 | 954 | 1,610 |
| Total current assets | 3,043 | 5,575 | 8,862 | 16,635 |
| Non-current restricted cash | NaN | NaN | 161 | 161 |
| Operating lease right-of-use assets | NaN | NaN | 2,091 | 4,959 |
| Property and equipment, net | NaN | NaN | 3,004 | 4,245 |
| In-process research and development (ipr&d) asset | 208 | 208 | 12,050 | 12,050 |
| Total non-current assets | NaN | 208 | 17,306 | 21,415 |
| Total assets | 3,251 | 5,783 | 26,168 | 38,050 |
| Current portion of lease liabilities | NaN | 1,436 | 1,296 | 1,233 |
| Trade account payables | 720 | 3,120 | 1,508 | 2,178 |
| Balance due biomx ltd | 1,254 | NaN | NaN | NaN |
| Other account payables | 473 | 1,823 | 2,422 | 2,851 |
| Total current liabilities | 2,447 | 6,379 | 5,226 | 6,262 |
| Operating lease liabilities, net of current portion | NaN | NaN | 5,287 | 8,143 |
| Other liabilities | NaN | NaN | 34 | 80 |
| Warrants | 1,685 | 706 | 5,135 | 4,405 |
| Total non-current liabilities | 1,685 | 706 | 10,456 | 12,628 |
| Total liabilities | 4,132 | NaN | NaN | NaN |
| Preferred stock, 0.0001 par value authorized - 1,000,000 shares as of march 31, 2026 and december 31, 2025. issued and outstanding 147,512 as of march 31, 2026 and 147,512 shares as of december 31, 2025 | 18,617 | 18,617 | 18,617 | 18,645 |
| Common stock, 0.0001 par value (common stock) authorized - 750,000,000 shares as of march 31, 2026 and december 31, 2025. issued and outstanding 6,543,703 and 1,593,703 as of march 31, 2026 and december 31, 2025, respectively | 7 | 7 | 7 | 7 |
| Receivables on account of shares | 3,300 | NaN | NaN | NaN |
| Additional paid-in capital | 219,831 | 196,970 | 195,421 | 194,901 |
| Accumulated deficit | -236,036 | -216,896 | -203,559 | -194,393 |
| Total capital deficiency | -881 | -1,302 | 10,486 | 19,160 |
| Total liabilities and capital deficiency | 3,251 | 5,783 | 26,168 | 38,050 |
BiomX Inc. (PHGE)
BiomX Inc. (PHGE)